Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
Repository Usage Stats
BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is whether hospitals accurately perceive their rate of tPA "door-to-needle" (DTN) time within 60 minutes and how DTN rates compare across different hospitals. METHODS AND RESULTS: DTN performance was defined by the percentage of treated patients who received tPA within 60 minutes of arrival. Telephone surveys were obtained from staff at 141 Get With The Guidelines hospitals, representing top, middle, and low DTN performance. Less than one-third (29.1%) of staff accurately identified their DTN performance. Among middle- and low-performing hospitals (n=92), 56 sites (60.9%) overestimated their performance; 42% of middle performers and 85% of low performers overestimated their performance. Sites that overestimated tended to have lower annual volumes of tPA administration (median 8.4 patients [25th to 75th percentile 5.9 to 11.8] versus 10.2 patients [25th to 75th percentile 8.2 to 17.3], P=0.047), smaller percentages of eligible patients receiving tPA (84.7% versus 89.8%, P=0.008), and smaller percentages of DTN ≤60 minutes among treated patients (10.6% versus 16.6%, P=0.002). CONCLUSIONS: Hospitals often overestimate their ability to deliver timely tPA to treated patients. Our findings indicate the need to routinely provide comparative provider performance rates as a key step to improving the quality of acute stroke care.
quality of care
Aged, 80 and over
Attitude of Health Personnel
Delivery of Health Care
Drug Administration Schedule
Health Care Surveys
Health Knowledge, Attitudes, Practice
Practice Guidelines as Topic
Practice Patterns, Physicians'
Quality Indicators, Health Care
Tissue Plasminogen Activator
Published Version (Please cite this version)10.1161/JAHA.114.001298
Publication InfoBritz, GW; Constable, M; Cox, M; Fonarow, GC; Lin, CB; Olson, DaiWai M; ... Shah, BR (2015). Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke. J Am Heart Assoc, 4(7). 10.1161/JAHA.114.001298. Retrieved from https://hdl.handle.net/10161/15000.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Fred Cobb, M.D. Professor of Medicine
Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical Research Institute (DCRI), Durham, NC, USA. Dr Peterson is the Principal Investigator of the National Institute of Health, Lung and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial He is also the Principal I
Showing items related by title, author, creator, and subject.
Stoertz, Aaron (2011)Health system strengthening is now recognized as a pressing global health priority. Motivated and productive health workers are a critical component of health systems. Low and middle-income countries need many more health ...
Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. Bolognesi, Michael Paul; Hug, KT; Koenig, L; Mather, Richard Charles III; Nunley, RM; Orlando, Lori Ann; Watters, TS (BMC Musculoskelet Disord, 2014-01-18)BACKGROUND: The projected demand for total knee arthroplasty is staggering. At its root, the solution involves increasing supply or decreasing demand. Other developed nations have used rationing and wait times to distribute ...
Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. Akwanalo, CO; Binanay, CA; Bloomfield, Gerald; Delong, AK; Finkelstein, Eric Andrew; Fuster, V; Hogan, JW; ... (16 authors) (Trials, 2014-04-27)BACKGROUND: Hypertension is the leading global risk factor for mortality. Hypertension treatment and control rates are low worldwide, and delays in seeking care are associated with increased mortality. Thus, a critical component ...